ADx logo

ALZHEIMER'S DISEASE AND DEMENTIA
IS A WORLDWIDE CHALLENGE
 

TODAY, NO CURE IS AVAILABLE

ADx NeuroSciences: R&D COMPANY FOR ACCURATE ALZHEIMER'S DIAGNOSIS

ADx NeuroSciences is a R&D company committed to improving the diagnosis of Alzheimer’s disease & dementia. The company identifies and develops novel biomarkers for accurate diagnosis and the effective treatment and follow-up of patients suffering from Alzheimer’s, Parkinson’s and other neurodegenerative diseases.

The new test generation for Alzheimer's disease diagnostics is now available through our partner EUROIMMUN.

Read More

ADx NeuroSciences develops and delivers:

Detection tools for precise, early and successful intervention:

Development of own proprietary stand-alone biomarkers and in-licensing of newly discovered markers from academic and industrial partners.

Companion diagnostics for improved and efficient drug development:

Development and co-development of tailor-made new generation companion diagnostics for neurodegenerative disorders.

Read More